Article
Association of EGFR mutation or ALK rearrangement with expression of DNA repair and synthesis genes in never-smoker women with pulmonary adenocarcinoma.
Cancer - 15 Nov 2012
Ren Shengxiang, Chen Xiaoxia, Kuang Peng, Zheng Limou, Su Chunxia, Li Jiayu, Li Bing, Wang Yongshen, Liu Lu, Hu Qiong, Zhang Jie, Tang Liang, Li Xuefei, Zhou Caicun, Schmid-Bindert Gerald
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement may predict the outcome of targeted drug therapy and also are associated with the efficacy of chemotherapy in patients with nonsmall cell lung cancer (NSCLC). The authors of this report...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
